Why the study?
The 2007 ESC Guidelines for managing ACS in patients presenting without persistent ST-segment elevation required updating with new recommendations on antiplatelet drugs, high-sensitive troponins, echocardiography, CT scans, and a bleeding risk score.
Provides updated ESC guideline recommendations for the management of patients with suspected non-ST-elevation acute coronary syndromes.
Answers are grounded in this paper and cite their sources.
Should guide management of suspected NSTE-ACS with updated antiplatelet and diagnostic strategies; extends prior ESC guidelines.
New recommendations are given on the use of antiplatelet drugs, high-sensitive troponins, echocardiography, CT scans, and a bleeding risk score. The European Society of Cardiology (ESC) Guidelines for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation were presented for the first time at the ESC Congress in Paris in August 2011 and have been published in European Heart Journal (EHJ). The Guidelines replace the document first published in 2000 and updated in 2002 and 2007.1 As in 2007, the Guidelines task force was co-chaired by Professor Christian W. Hamm, professor of internal medicine and cardiology, medical director of the Kerckhoff Heart and Thorax Center, Bad Nauheim, and medical director of the Medical Clinic I, University of Giessen, Germany, and Professor Jean-Pierre Bassand, chief of the Department of Cardiology, University Hospital Jean Minjoz, Besançon, France. Bassand was the lead co-chair for the 2007 guidelines and Hamm takes that role for the 2011 document.
No takes yet. Share an insight, caveat, or question.
A 2011 study studied Non-ST-elevation acute coronary syndromes. The 2011 ESC Guidelines update recommendations on antiplatelet drugs, high-sensitive troponins, imaging, and bleeding risk scores for non-ST-elevation ACS.
Synapse has enriched 10 related papers. Consider them for comparative context: